| 1 |
Siegel R, Miller K, Fuchs HE, et al. Cancer statistics, 2021[J].CA Cancer J Clin, 2021, 71(1): 7-33.
|
| 2 |
高嘉营，金发光. 肺癌自身抗体在肺癌诊断中的研究进展[JO/L]. 中华肺部疾病杂志(电子版), 2023, 16(5): 739-741.
|
| 3 |
重庆肺癌精准治疗协作组(CPLOG), 重庆市医药生物技术协会肿瘤罕见病疑难病专委会，重庆市医学会肿瘤学分会化疗学组. 非小细胞肺癌三代表皮生长因子受体酪氨酸激酶抑制剂耐药后诊疗策略专家共识(2025版)[JO/L]. 中华肺部疾病杂志(电子版), 2025, 18(6): 847-859.
|
| 4 |
Travis WD, Brambilla E, Burke AP, et al. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, Thymus, and heart[J]. J Thorac Oncol, 2015, 10(9): 1240-1242.
|
| 5 |
Chen PY, Quan Z, Song XY, et al. MDFI is a novel biomarker for poor prognosis in LUAD[J]. Front Oncol, 2022, 12: 1005962.
|
| 6 |
Singh SS, Dahal A, Shrestha L, et al. Genotype driven therapy for non-small cell lung cancer: Resistance, pan inhibitors and immunotherapy[J]. Curr Med Chem, 2020, 27(32): 5274-5316.
|
| 7 |
Cascone T, Fradette J, Pradhan M, et al. Tumor immunology and immunotherapy of non-small-cell lung cancer[J]. Cold Spring Harb Perspect Med, 2022, 12(5): a037895.
|
| 8 |
万思远，林志星，廖薇薇，等. 抗IL-13单抗抑制上呼吸道杯状细胞增生缓解急性声门下喉炎的疗效及分子机制研究[J]. 国际检验医学杂志，2025, 46(2): 168-174.
|
| 9 |
樊蕊蕊，高杰. 原发性直肠杯状细胞腺癌的临床病理研究[J]. 诊断病理学杂志，2024, 31(10): 976-979, 988.
|
| 10 |
Gustafsson JK, Johansson MEV. The role of goblet cells and mucus in intestinal homeostasis[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(12): 785-803.
|
| 11 |
Dimmler A, Geddert H, Faller G. EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix[J]. Pathol Res Pract, 2014, 210(5): 274-278.
|
| 12 |
Alam J, de PaivaCS, Pflugfelder SC. Immune-Goblet cell interaction in the conjunctiva[J]. Ocul Surf, 2020, 18(2): 326-334.
|
| 13 |
Cui Y, Fang W, Li C, et al. Development and validation of a novel signature to predict overall survival in "Driver Gene-negative" Lung Adenocarcinoma (LUAD): Results of a multicenter study[J]. Clin Cancer Res, 2019, 25(5): 1546-1556.
|
| 14 |
Serafini A, Tan L, Horswell S, et al. Mycobacterium tuberculosis requires glyoxylate shunt and reverse methylcitrate cycle for lactate and pyruvate metabolism[J]. Mol Microbiol, 2019, 112(4): 1284-1307.
|
| 15 |
Zhou L, Wang H, Fang Z, et al. The microRNA-381(miR-381)/Spindlin1(SPIN1) axis contributes to cell proliferation and invasion of colorectal cancer cells by regulating the Wnt/β-catenin pathway[J]. Bioengineered, 2021, 12(2): 12036-12048.
|
| 16 |
Kosriwong K, Menheniott TR, Giraud AS, et al. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma[J]. World J Gastroenterol, 2011, 17(12): 1631-1641.
|
| 17 |
Romano E, Vllahu M, Bizzarro V, et al. TFF1 promotes EMT-like changes through an auto-induction mechanism[J]. Int J Mol Sci, 2018, 19(7): 2018.
|
| 18 |
Buijs JT, van BeijnumR, Anijs RJS, et al. The association of tumor-expressed REG4, SPINK4 and alpha-1 antitrypsin with cancer-associated thrombosis in colorectal cancer[J]. J Thromb Thrombolysis, 2024, 57(3): 370-380.
|
| 19 |
Fournier AK, Campbell LE, Castagnino P, et al. Rac-dependent cyclin D1 gene expression regulated by cadherin- and integrin-mediated adhesion[J]. J Cell Sci, 2008, 121(Pt 2): 226-233.
|
| 20 |
De FeliceB, Damiano S, Montanino C, et al. Effect of beta- and alpha-glucans on immune modulating factors expression in enterocyte-like Caco-2 and goblet-like LS 174T cells[J]. Int J Biol Macromol, 2020，153: 600-607.
|
| 21 |
Lu Y, Huang Y, Li J, et al. Eosinophil extracellular traps drive asthma progression through neuro-immune signals[J]. Nat Cell Biol, 2021, 23(10): 1060-1072.
|
| 22 |
Su H, Zhao Y. Eupatilin alleviates inflammation and epithelial-to-mesenchymal transition in chronic rhinosinusitis with nasal polyps by upregulating TFF1 and inhibiting the Wnt/β-catenin signaling pathway[J]. Histol Histopathol, 2024, 39(3): 357-365.
|
| 23 |
Zhao S, Ma Y, Huang X. Trefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling[J]. Int J Clin Exp Pathol, 2015, 8(9): 10412-10419.
|
| 24 |
Chen TJ, Tian YF, Chou CL, et al. High SPINK4 expression predicts poor outcomes among rectal cancer patients receiving CCRT[J]. Curr Oncol, 2021, 28(4): 2373-2384.
|
| 25 |
Wang Y, Han J, Yang G, et al. Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis[J]. Nat Commun, 2024, 15(1): 5874.
|
| 26 |
Hasebe K, Yamazaki K, Yamaguchi J, et al. Trefoil factor 1 inhibits the development of esophageal adenocarcinoma from Barrett′s epithelium[J]. Lab Invest, 2022, 102(8): 885-895.
|
| 27 |
Chen TJ, Tian YF, Chou CL, et al. High SPINK4 expression predicts poor outcomes among rectal cancer patients receiving CCRT[J]. Curr Oncol, 2021, 28(4): 2373-2384.
|
| 28 |
Blanchard C, Durual S, Estienne M, et al. IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis[J]. J Immunol, 2004, 172(6): 3775-3783.
|
| 29 |
Hahn C, Teufel M, Herz U, et al. Inhibition of the IL-4/IL-13 receptor system prevents allergic sensitization without affecting established allergy in a mouse model for allergic asthma[J]. J Allergy Clin Immunol, 2003, 111(6): 1361-1369.
|
| 30 |
Graziani F, Pinton P, Olleik H, et al. Deoxynivalenol inhibits the expression of trefoil factors (TFF) by intestinal human and porcine goblet cells[J]. Arch Toxicol, 2019, 93(4): 1039-1049.
|
| 31 |
Pothuraju R, Rachagani S, Krishn SR, et al. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance[J]. Mol Cancer, 2020, 19(1): 37.
|
| 32 |
Manne A, Kasi A, Esnakula AK, et al. Predictive value of MUC5AC signature in pancreatic ductal adenocarcinoma: A hypothesis based on preclinical evidence[J]. Int J Mol Sci, 2023, 24(9): 8087.
|
| 33 |
Fan J, Chen B, Wu H, et al. Comprehensive multi-omics analysis identifies chromatin regulator-related signatures and TFF1 as a therapeutic target in lung adenocarcinoma through a 429-combination machine learning approach[J]. Front Immunol, 2024, 15: 1481753.
|